Advance Program | ADA 82nd Scientific Sessions - 18

ADVANCE PROGRAM
SCIENTIFIC PROGRAM
FRIDAY, JUNE 3
11:30 a.m.-12:30 p.m.
* From Paper to Practice-The
Bridge Between Research and
Clinical Practice in Preventing
Diabetes Foot Complications
Innovations in Diabetes Foot
Complication Translational Research
Laura Shin, DPM, PhD
Bringing Translational Research into
Daily Clinics
Amanda L. Killeen, DPM, CWSP,
FACPM
Questions and Discussion Period
* Statins in Diabetes
Use of Statins in Type 1 Diabetes
Naveed Sattar, MD, PhD
Statin Use and Diabetes-What's the
Connection?
David Preiss, MBChB, MRCP,
FRCPath, PhD
Question and Discussion Period
* What is New in Diabetic Retinopathy
Screening and Grading?
How Should Artificial Intelligence
Influence Screening Intervals?
Tunde Peto, MD, PhD
New JDRF Diabetic Retinal Disease
Staging System
Sobha Sivaprasad, MD
Question and Discussion Period
* Real-Time, Real-Life Measurement
of the Patient Experience with Blood
Glucose Management-Ecological
Momentary Assessment and
Continuous Glucose Monitoring
Function and Emotion in Everyday Life
with Type 1 Diabetes-The FEEL-T1D
Study
Elizabeth Pyatak, PhD, CDCES
Glycemic Variability and Fluctuations in
Cognitive Status in Adults with Type 1
Diabetes
Laura Germine, PhD
Living with Diabetes and Well-Being in
Everyday Life among Adults with
Type 2 Diabetes-The German DIALINK
2 Study
Norbert Hermanns, PhD
* Updates on Type 2 Diabetes in
Pregnancy-Clinical Outcomes and
Pathophysiology
Adverse Clinical Outcomes in
Pregnancy for Women with Type 2
Diabetes-Maternal-Fetal Mortality
and Morbidity
Jeanie B. Tryggestad, MD
Placenta Pathophysiology in Women
with T2D Diabetes in Pregnancy
Perrie F. O'Tierney-Ginn, PhD
Question and Discussion Period
* Genetics of NASH/NAFLD-
Guidance for Prediction and
Treatment
NAFLD and Obesity-A Global
Problem for Diagnosis, Management
and Treatment
Elizabeth K. Speliotes, MD, PhD, MPH
Genetics of NAFLD in the Million
Veteran Program
Marijana Vujkovic, PhD
Question and Discussion Period
* Emerging Data on the Immune-Islet
Interface in Diabetes
Three-Dimensional View of the
Pancreas in Type 1 Diabetes
Mark A. Atkinson, PhD
Beta Cells in Type 1 Diabetes-More
than an Innocent Bystander
Raghavendra G. Mirmira, MD, PhD
Question and Discussion Period
* Top 5 Nutrition Controversies
Artificial Sweeteners-Food Labels-
Net-carbs and Fiber; Are Very Low
Carbohydrate Eating Plans Safe?
Maureen Chomko, RDN, CDCES
Meal and Snack Frequency-Which
Matters More-Macronutrients or
Calories?
Alison Evert, MS, RDN, CDCES
Question and Discussion Period
* Diabetes through a Health Equity
Lens
NIDDK Perspective
Clinical Perspective
Joshua J. Joseph, MD, MPH, FAHA
Question and Discussion Period
* Machine Learning in Diabetes
Understanding Metabolic Changes
Using Machine Learning
Mohit Jain, MD, PhD
Machine Learning Methods for
Mapping Neuronal Circuits
Srinivas C. Turaga, PhD
Machine Learning in Exercise
Metabolism
David E. James, FAA
* COVID-19 and Diabetes
SARS-CoV-2 Infection Induces BetaCell
Transdifferentiation
Shuibing Chen, PhD
Coronavirus Induces Diabetic
Macrophage-Mediated Inflammation via
SETDB2
12:45 p.m.-1:45 p.m.
* Hypoglycemia, CGM Metrics, and
HbA1c-Patient and Clinician
Perspectives
Hypoglycemia, CGM Metrics, and
HbA1c-A Patient Perspective
Anna Kasper, RN, CDCES
Hypoglycemia, CGM Metrics, and
HbA1c-Clinician Perspective
Pratik Choudhary, MD
Question and Discussion Period
* Improving Outcomes-A
Multidisciplinary Year in Review
Cardiology Perspective-A Consensus
Report of the American Diabetes
Association on Heart Failure, the
Under-Appreciated Complication of
Diabetes
James L Januzzi Jr., MD
Nephrology Perspective
Tamara Isakova MD, MMSc
Diabetology Perspective
Neda Rasouli, MD
Question and Discussion Period
* Clinical Advances in ReninAngiotensin-Aldosterone
System
Blockade
Mineralocorticoid Antagonism-A New
Tool for Patients with Type 2 Diabetes
and CKD
Csaba P. Kovesdy, MD
How do I Deal with Hyperkalemia?
Question and Discussion Period
HYBRID | NEW ORLEANS | JUNE 3-7, 2022 | #ADA2022
18

Advance Program | ADA 82nd Scientific Sessions

Table of Contents for the Digital Edition of Advance Program | ADA 82nd Scientific Sessions

Advance Program | ADA 82nd Scientific Sessions - 1
Advance Program | ADA 82nd Scientific Sessions - 2
Advance Program | ADA 82nd Scientific Sessions - 3
Advance Program | ADA 82nd Scientific Sessions - 4
Advance Program | ADA 82nd Scientific Sessions - 5
Advance Program | ADA 82nd Scientific Sessions - 6
Advance Program | ADA 82nd Scientific Sessions - 7
Advance Program | ADA 82nd Scientific Sessions - 8
Advance Program | ADA 82nd Scientific Sessions - 9
Advance Program | ADA 82nd Scientific Sessions - 10
Advance Program | ADA 82nd Scientific Sessions - 11
Advance Program | ADA 82nd Scientific Sessions - 12
Advance Program | ADA 82nd Scientific Sessions - 13
Advance Program | ADA 82nd Scientific Sessions - 14
Advance Program | ADA 82nd Scientific Sessions - 15
Advance Program | ADA 82nd Scientific Sessions - 16
Advance Program | ADA 82nd Scientific Sessions - 17
Advance Program | ADA 82nd Scientific Sessions - 18
Advance Program | ADA 82nd Scientific Sessions - 19
Advance Program | ADA 82nd Scientific Sessions - 20
Advance Program | ADA 82nd Scientific Sessions - 21
Advance Program | ADA 82nd Scientific Sessions - 22
Advance Program | ADA 82nd Scientific Sessions - 23
Advance Program | ADA 82nd Scientific Sessions - 24
Advance Program | ADA 82nd Scientific Sessions - 25
Advance Program | ADA 82nd Scientific Sessions - 26
Advance Program | ADA 82nd Scientific Sessions - 27
Advance Program | ADA 82nd Scientific Sessions - 28
Advance Program | ADA 82nd Scientific Sessions - 29
Advance Program | ADA 82nd Scientific Sessions - 30
Advance Program | ADA 82nd Scientific Sessions - 31
Advance Program | ADA 82nd Scientific Sessions - 32
https://www.nxtbookmedia.com